HI SB857 | 2024 | Regular Session
Note: Carry Over of previous SB857
Status
Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on January 20 2023 - 25% progression
Action: 2023-12-11 - Carried over to 2024 Regular Session.
Pending: Senate Commerce and Consumer Protection Committee
Text: Latest bill text (Amended) [HTML]
Status: Introduced on January 20 2023 - 25% progression
Action: 2023-12-11 - Carried over to 2024 Regular Session.
Pending: Senate Commerce and Consumer Protection Committee
Text: Latest bill text (Amended) [HTML]
Summary
Beginning on January 1, 2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 12/31/2050. (SD1)
Title
Relating To Access To Treatment For Terminally Ill Patients.
Sponsors
| Sen. Stanley Chang [D] | Sen. Gil Keith-agaran [D] | Sen. Angus McKelvey [D] | Sen. Donovan Cruz [D] |
| Sen. Michelle Kidani [D] |
Roll Calls
2023-02-06 - Senate - Senate Health and Human Services: Passed, With Amendments (Y: 5 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-12-11 | Carried over to 2024 Regular Session. | |
| 2023-02-17 | Senate | Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC. |
| 2023-02-17 | Senate | Reported from HHS (Stand. Com. Rep. No. 449) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN/JDC. |
| 2023-02-06 | Senate | The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Moriwaki, Shimabukuro, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none. |
| 2023-02-03 | Senate | The committee(s) on HHS has scheduled a public hearing on 02-06-23 1:00PM; Conference Room 225 & Videoconference. |
| 2023-01-27 | Senate | Referred to HHS, CPN/JDC. |
| 2023-01-23 | Senate | Passed First Reading. |
| 2023-01-20 | Senate | Introduced. |
Same As/Similar To
SB857 (Carry Over) 2023-02-17 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN/JDC.
HB966 (Same As) 2024-02-08 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Nakashima, Nishimoto, Sayama, Ward excused (4).
HB966 (Same As) 2024-02-08 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Nakashima, Nishimoto, Sayama, Ward excused (4).
